Incisional Hernias, Ventral Hernias
Conditions
Brief summary
This prospective early feasibility clinical study will collect information regarding the safety and efficacy of the Cook® Antimicrobial Hernia Repair Device to reinforce soft tissue during ventral or incisional hernia repair in clean-contaminated and contaminated (i.e., Class II and Class III) surgical fields.
Interventions
hernia repair
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient with ventral or incisional hernia that is to be surgically corrected in a Class II and Class III surgical field.
Exclusion criteria
* Less than 21 years old * Unwilling or unable to sign and date the informed consent * Pregnant, breastfeeding, or planning to become pregnant prior to completing the study * Unable or unwilling to comply with follow-up schedule * Simultaneously participating in another investigational drug or device study. * Medical condition or disorder that would limit life expectancy to less than the primary clinical study endpoint.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients that develop a surgical site infection | 6 months | Surgical site infections (SSI) that will be included in this outcome measure are deep incisional, organ/space, and superficial incisional. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of hernia recurrences | 24 months | Hernia recurrences is the protrusion of abdominal tissue through a defect in the abdominal wall at the site of the hernia repaired during the index procedure. |
| Frequency of procedural and post-operative adverse events | 24 months | The adverse events will be bowel erosion, bowl obstruction, delayed wound infection, fever, fistula formation, graft contraction, hernia recurrence, ileus, need for revision/resurgery, pain, premature degradation, wound dehiscence, and other wound complications. |